Dallas, TX – NEOMEDIA TECHNOLOGIES INCORPORATED (OTCBB: NEOM) "Up 35.00% in morning trading"
NeoMedia Technologies, Inc. is the global leader in mobile barcode scanning solutions. The company's technology allows mobile devices with cameras to read 1D and 2D barcodes and provide “one click” access to mobile content. Combining this technology with advanced analytics and reporting capabilities revolutionizes the way advertisers market to mobile consumers. NeoMedia provides the infrastructure to make 2D camera barcode scanning and its associated commerce easy, universal, and reliable — worldwide.
MASS HYSTERIA ENTERTAINMENT COMPANY (OTC: MHYS) "Up 33.33% in morning trading"
Mass Hysteria Entertainment, Inc. is a multi-media entertainment company created to produce films with an interactive component. The Company most recently completed production in Louisiana on CARJACKED starring Maria Bello and Stephen Dorff. Anchor Bay acquired domestic and English speaking territories and CMG is selling the picture internationally. Mass Hysteria also recently acquired the rights to the romantic comedy SLEEPING TOGETHER written by Steve Smith and Phill Traill and to be directed by Traill.
SPHERIX INCORPORATED (NASDAQ: SPEX) "Up 40.33% in morning trading"
Spherix Incorporated was launched in 1967 as a scientific research company under the name Biospherics Research. The company now leverages its scientific and technical expertise and experience through its two subsidiaries — Biospherics Incorporated and Spherix Consulting, Inc. Biospherics is dedicated to developing and licensing/marketing proprietary therapeutic products for treatment of diabetes, metabolic syndrome and atherosclerosis. Biospherics is actively seeking a pharmaceutical partner to continue the development of its Phase 3 compound for the treatment of diabetes, D-tagatose, while exploring new drugs and combinations for treatment of high triglycerides, a risk factor for atherosclerosis, myocardial infarction, and stroke. Spherix's Consulting subsidiary provides scientific and strategic support for suppliers, manufacturers, distributors and retailers of conventional foods, biotechnology-derived foods, medical foods, infant formulas, food ingredients, dietary supplements, food contact substances, pharmaceuticals, medical devices, consumer products and industrial chemicals and pesticides.
DISCOVERY LABS INCORPORATED (NASDAQ: DSCO) "Up 18.93% in morning trading"
Discovery Laboratories, Inc. is a biotechnology company developing Surfactant Therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs' novel proprietary KL4 Surfactant Technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations. In addition, Discovery Labs' proprietary Capillary Aerosolization Technology produces a dense aerosol, with a defined particle size that is capable of potentially delivering aerosolized KL4 surfactant to the deep lung without the complications currently associated with liquid surfactant administration. Discovery Labs is focused initially on developing its KL4 surfactant pipeline to build a pediatric franchise that will potentially address several respiratory conditions affecting neonates and young children, beginning with Respiratory Distress Syndrome (RDS).
OTCPicks.com, one of the leading penny stock Web sites, presents its daily Stocks to Watch and Midday Market Movers every weekday. In addition to all the latest penny stock news, OTCPicks also offers daily newsletters, unique commentaries and free profiles, alerts and investing tips.
The stocks presented above are available in OTCPicks.com's Free Daily Email Newsletter. For daily stock alerts go to www.otcpicks.com to sign up.
Disclosure: OTCPicks.com and affiliates have not been compensated by any of the companies covered in this release.
